产品
编 号：F368383
分子式：C10H6N4O2
分子量：214.18
分子式：C10H6N4O2
分子量：214.18
产品类型
规格
价格
是否有货
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
100mg
询价
询价
结构图
CAS No: 490-59-5
产品详情
生物活性：
Alloxazine is a selective A2b antagonist. Alloxazine completely block 5’N-Ethylcarboxamido adenosine (NECA)-mediated cyclic AMP accumulation with an IC50 of 2.9 μM. Alloxazine can be used for the research of cancer.
体内研究：
Alloxazine (1 μmol/L; cortical surface suffusion for 0-20 min) suppresses NECA-induced vasodilation.Animal Model:Male Sprague-Dawley rats
Dosage:1 μmol/L
Administration:Cortical surface suffusion; 1 μmol/L once
Result:Significantly suppressed vasodilation with increased EC25 value of 0.60 μmol/L.
体外研究：
Alloxazine (0-30 μM, 20 min) inhibits cyclic AMP production in PGT-β cells.
Alloxazine is a selective A2b antagonist. Alloxazine completely block 5’N-Ethylcarboxamido adenosine (NECA)-mediated cyclic AMP accumulation with an IC50 of 2.9 μM. Alloxazine can be used for the research of cancer.
体内研究：
Alloxazine (1 μmol/L; cortical surface suffusion for 0-20 min) suppresses NECA-induced vasodilation.Animal Model:Male Sprague-Dawley rats
Dosage:1 μmol/L
Administration:Cortical surface suffusion; 1 μmol/L once
Result:Significantly suppressed vasodilation with increased EC25 value of 0.60 μmol/L.
体外研究：
Alloxazine (0-30 μM, 20 min) inhibits cyclic AMP production in PGT-β cells.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备